The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Liquid biopsy: monitoring cancer-genetics in the blood
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002003 · Cited by 3,499
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
APC mutations occur early during colorectal tumorigenesis
Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., & Kinzler, K. W. (1992) · Nature · doi:10.1038/359235a0 · Cited by 1,924
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Cohn, S. L., Pearson, A. D. J., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6785 · Cited by 1,910
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
Self-citationAnti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911123 · Cited by 1,835
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Bean, J., Brennan, C., Shih, J.-Y., Riely, G., Viale, A., Wang, L., Chitale, D., Motoi, N., Szoke, J., Broderick, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710370104 · Cited by 1,598
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
Li, D., Ambrogio, L., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., Padera, R. F., Shapiro, G. I., Baum, A., Himmelsbach, F., et al. (2008) · Oncogene · doi:10.1038/onc.2008.109 · Cited by 1,447
Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids
Srinivasan, M., Sedmak, D., & Jewell, S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64472-0 · Cited by 1,318
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Villanueva, J., Vultur, A., Lee, J. T., Somasundaram, R., Fukunaga-Kalabis, M., Cipolla, A. K., Wubbenhorst, B., Xu, X., Gimotty, P. A., Kee, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.023 · Cited by 1,259
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., Abdel-Rahman, M., Wang, X., Levine, A. D., Rho, J. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2330 · Cited by 1,224
Nuclear Acids In Human Blood Plasma.
Mandel, P., & Métais, P. (1948) · PubMed · Cited by 1,196
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Choi, Y. L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007478 · Cited by 1,189
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Turke, A. B., Zejnullahu, K., Wu, Y.-L., Song, Y., Dias-Santagata, D., Lifshits, E., Toschi, L., Rogers, A., Mok, T., Sequist, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.022 · Cited by 1,059
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Zhou, W., Ercan, D., Chen, L., Yun, C.-H., Li, D., Capelletti, M., Cortot, A. B., Chirieac, L., Iacob, R. E., Padera, R., et al. (2009) · Nature · doi:10.1038/nature08622 · Cited by 1,013
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Wagle, N., Emery, C., Berger, M. F., Davis, M. J., Sawyer, A., Pochanard, P., Kehoe, S. M., Johannessen, C. M., MacConaill, L. E., Hahn, W. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2312 · Cited by 1,005
Matthay, K. K., Reynolds, C. P., Seeger, R. C., Shimada, H., Adkins, E. S., Haas-Kogan, D., Gerbing, R. B., London, W. B., & Villablanca, J. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8925 · Cited by 858
Balak, M. N., Gong, Y., Riely, G. J., Somwar, R., Li, A. R., Zakowski, M. F., Chiang, A., Yang, G., Ouerfelli, O., Kris, M. G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1570 · Cited by 824
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. (2013) · Science · doi:10.1126/science.1227670 · Cited by 744
About the possible origin and mechanism of circulating DNA
Stroun, M., Lyautey, J., Lederrey, C., Olson-Sand, A., & Anker, P. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00665-9 · Cited by 740
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, M., Salangsang, F., Landman, A. S., Sellers, W. R., Pryer, N. K., Levesque, M. P., Dummer, R., McMahon, M., & Stuart, D. D. (2013) · Nature · doi:10.1038/nature11814 · Cited by 730
Engelman, J. A., Zejnullahu, K., Gale, C.-M., Lifshits, E., Gonzales, A. J., Shimamura, T., Zhao, F., Vincent, P. W., Naumov, G. N., Bradner, J. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1885 · Cited by 730
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., Hider, P. N., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub3 · Cited by 640
Shi, H., Moriceau, G., Kong, X., Lee, M.-K., Lee, H., Koya, R. C., Ng, C., Chodon, T., Scolyer, R. A., Dahlman, K. B., et al. (2012) · Nature Communications · doi:10.1038/ncomms1727 · Cited by 640
Leary, R. J., Sausen, M., Kinde, I., Papadopoulos, N., Carpten, J. D., Craig, D., O’Shaughnessy, J., Kinzler, K. W., Parmigiani, G., Vogelstein, B., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004742 · Cited by 635
(2015) · Security Intelligence · doi:10.1002/9781119183617.ch8 · Cited by 600
Kosaka, T., Yatabe, Y., Endoh, H., Yoshida, K., Hida, T., Tsuboi, M., Tada, H., Kuwano, H., & Mitsudomi, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0714 · Cited by 589
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Nickerson, M. L., Jaeger, E., Shi, Y., Durocher, J. A., Mahurkar, S., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4921 · Cited by 588
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., Westerga, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1077 · Cited by 537
Parameters of the human genome.
Morton, N. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7474 · Cited by 516
Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
Isakoff, S. J., Engelman, J. A., Irie, H. Y., Luo, J., Brachmann, S. M., Pearline, R. V., Cantley, L. C., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2612 · Cited by 509
Chan, K. A., Jiang, P., Zheng, Y. W., Liao, G. J., Sun, H., Wong, J., Siu, S. S. N., Chan, W. C., Chan, S. L., Chan, A. T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196014 · Cited by 488
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers
Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K. V., Parmigiani, G., Kinzler, K. W., et al. (2003) · Science · doi:10.1126/science.1082596 · Cited by 484
Self-citationALK in Lung Cancer: Past, Present, and Future
Shaw, A. T., & Engelman, J. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5353 · Cited by 461
Gormally, E., Caboux, E., Vineis, P., & Hainaut, P. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.11.002 · Cited by 445
Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 421
Punnoose, E. A., Atwal, S., Liu, W., Raja, R., Fine, B. M., Hughes, B. G. M., Hicks, R. J., Hampton, G. M., Amler, L. C., Pirzkall, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3148 · Cited by 415
Ambros, P. F., Ambros, I. M., Brodeur, G. M., Haber, M., Khan, J., Nakagawara, A., Schleiermacher, G., Speleman, F., Spitz, R., London, W. B., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605014 · Cited by 404
Roles for KRAS in Pancreatic Tumor Development and Progression
di Magliano, M. P., & Logsdon, C. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.071 · Cited by 400
Watanabe, S., Tanaka, J., Ota, T., Kondo, R., Tanaka, H., Kagamu, H., Ichikawa, K., Koshio, J., Baba, J., Miyabayashi, T., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-1 · Cited by 394
Yung, T. K. F., Chan, K. C. A., Mok, T. S. K., Tong, J., To, K.-F., & Lo, Y. M. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2622 · Cited by 385
Heitzer, E., Ulz, P., Belic, J., Gutschi, S., Quehenberger, F., Fischereder, K., Benezeder, T., Auer, M., Pischler, C., Mannweiler, S., et al. (2013) · Genome Medicine · doi:10.1186/gm434 · Cited by 357
Tailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Taniguchi, K., Uchida, J., Nishino, K., Kumagai, T., Okuyama, T., Okami, J., Higashiyama, M., Kodama, K., Imamura, F., & Kato, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1712 · Cited by 315
Press, M. F., Sauter, G., Bernstein, L., Villalobos, I. E., Mirlacher, M., Zhou, J.-Y., Wardeh, R., Li, Y.-T., Guzman, R., Ma, Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0636 · Cited by 311
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Higgins, M. J., Jelovac, D., Barnathan, E., Blair, B., Slater, S., Powers, P., Zorzi, J., Jeter, S. C., Oliver, G. R., Fetting, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2696 · Cited by 309
Implementing personalized cancer genomics in clinical trials
Simon, R., & Roychowdhury, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3979 · Cited by 301
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Bielack, S., Carrle, D., & Casali, P. G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp154 · Cited by 276
García-Olmo, D. C., Domínguez, C., García-Arranz, M., Anker, P., Stroun, M., García-Verdugo, J. M., & García-Olmo, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3513 · Cited by 267
Controversies in clinical cancer dormancy
Uhr, J. W., & Pantel, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106613108 · Cited by 251
Spindler, K.-L. G., Pallisgaard, N., Vogelius, I., & Jakobsen, A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0564 · Cited by 251
Koffler, D., Agnello, V., Winchester, R., & Kunkel, H. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107165 · Cited by 248
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234
Castells, A., Puig, P., Móra, J., Boadas, J., Boix, L., Urgell, E., Solé, M., Capellà, G., Lluís, F., Fernández-Cruz, L., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.578 · Cited by 222
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., & Hider, P. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub2 · Cited by 205
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Board, R. E., Wardley, A. M., Dixon, J. M., Armstrong, A. C., Howell, S., Renshaw, L., Donald, E., Greystoke, A., Ranson, M., Hughes, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0747-9 · Cited by 201
Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non–Small-Cell Lung Cancer
Bai, H., Wang, Z., Chen, K., Zhao, J., Lee, J. J., Wang, S., Zhou, Q., Zhuo, M., Mao, L., An, T., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.3744 · Cited by 199
McBride, D. J., Orpana, A. K., Sotiriou, C., Joensuu, H., Stephens, P. J., Mudie, L. J., Hämäläinen, E., Stebbings, L. A., Andersson, L. C., Flanagan, A. M., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20815 · Cited by 196
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen, X., Bonnefoi, H. R., Diebold‐Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E. F., Stroun, M., & Anker, P. (1999) · PubMed · Cited by 193
Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
D'Addario, G., & Felip, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp132 · Cited by 187
Cortot, A. B., Repellin, C. E., Shimamura, T., Capelletti, M., Zejnullahu, K., Ercan, D., Christensen, J. G., Wong, K.-K., Gray, N. S., & Jänne, P. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2066 · Cited by 185
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Shaw, J. A., Page, K., Blighe, K., Hava, N., Guttery, D., Ward, B., Brown, J., Ruangpratheep, C., Stebbing, J., Payne, R., et al. (2012) · Genome Research · doi:10.1101/gr.123497.111 · Cited by 180
Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
Gevensleben, H., Garcia-Murillas, I., Graeser, M. K., Schiavon, G., Osin, P., Parton, M., Smith, I. E., Ashworth, A., & Turner, N. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3768 · Cited by 172
Wang, J., Hsieh, J., Chang, M., Huang, T., Chen, F., Cheng, T., Alexandersen, K., Huang, Y., Tzou, W., & Lin, S. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7366-8 · Cited by 167
Shinozaki, M., O'Day, S. J., Kitago, M., Amersi, F., Kuo, C., Kim, J., Wang, H.-J., & Hoon, D. S. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2120 · Cited by 164
Yamada, T., Nakamori, S., Ohzato, H., Oshima, S., Aoki, T., HIGAKI, N., Sugimoto, K., Akagi, K., Fujiwara, Y., Nishisho, I., et al. (1998) · PubMed · Cited by 159
Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen
Rogers, J. C., Boldt, D., Kornfeld, S., Skinner, S. A., & Valeri, C. R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.7.1685 · Cited by 158
Cancer cell adaptation to chemotherapy
Nicolantonio, F. D., Mercer, S. J., Knight, L. A., Gabriel, F. G., Whitehouse, P. A., Sharma, S., Fernando, A., Glaysher, S., Palma, S. D., Johnson, P., et al. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-78 · Cited by 153
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
Perkins, G., Yap, T. A., Pope, L., Mulick, A. R., Dukes, J. P., Riisnaes, R., Massard, C., Cassier, P. A., Miranda, S., Clark, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047020 · Cited by 152
International Cancer Genome Consortium
Berger, D. (2013) · Im Focus Onkologie · doi:10.1007/s15015-013-0268-6 · Cited by 148
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Anker, P., Herrera‐Goepfert, R., Medina-Velázquez, L. A., Hidalgo‐Miranda, A., Pérez‐Montiel, D., Chávez-Blanco, A. D., Cruz, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052754 · Cited by 145
Frattini, M., Gallino, G., Signoroni, S., Balestra, D., Lusa, L., Battaglia, L., Sozzi, G., Bertario, L., Leo, E., Pilotti, S., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.021 · Cited by 142
Silva, J. M., Silva, J., Sánchez, A., Garcia, J. M., Domínguez, G., Provencio, M., Sanfrutos, L., Jareño, E., Colas, A., España, P., et al. (2002) · PubMed · Cited by 142
Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Kataja, V. V., & Castiglione, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp114 · Cited by 135
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
Nygaard, A. D., Spindler, K. G., Pallisgaard, N., Andersen, R. F., & Jakobsen, A. K. M. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.11.016 · Cited by 128
Cardoso, F., & Castiglione, M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp115 · Cited by 126
Targeted therapies: how personal should we go?
Martini, M., Vecchione, L., Siena, S., Tejpar, S., & Bardelli, A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.164 · Cited by 124
Self-citationCross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
Cui, J., Germer, K., Wu, T., Wang, J., Luo, J., Wang, S., Wang, Q., & Zhang, X. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1305 · Cited by 124
Translational genomics: The challenge of developing cancer biomarkersPreprint
Brooks, J. D. (2012) · Genome Research · doi:10.1101/gr.124347.111 · Cited by 123
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
Mead, R. J., Duku, M., Bhandari, P., & Cree, I. A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.230 · Cited by 122
Brevet, M., Johnson, M. L., Azzoli, C. G., & Ladanyi, M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.014 · Cited by 120
Maak, M., Simón, I., Nitsche, U., Roepman, P., Snel, M. H. J., Glas, A. M., Schuster, T., Keller, G., Zeestraten, E. C. M., Goossens, I., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827c1180 · Cited by 120
Fine-needle aspiration (FNA) biopsy: historical aspects.
Diamantis, A., Magiorkinis, E., & Koutselini, H. (2009) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-009-0027-x · Cited by 114
Rechsteiner, M., von Teichman, A., Nowicka, A., Sulser, T., Schraml, P., & Moch, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0757 · Cited by 112
Santarpia, L., Qi, Y., Stemke‐Hale, K., Wang, B., Young, E. J., Booser, D. J., Holmes, F. A., O’Shaughnessy, J., Hellerstedt, B. A., Pippen, J., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2035-3 · Cited by 109
Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer
Ruth E. Board, Williams, V. S., Knight, L., Shaw, J., Greystoke, A., Ranson, M., Dive, C., Blackhall, F. H., & Hughes, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.020 · Cited by 106
Fate of Injected Deoxyribonucleic Acid in Mice
Tsumita, T., & Iwanaga, M. (1963) · Nature · doi:10.1038/1981088a0 · Cited by 104
Tamborini, E., Pricl, S., Negri, T., Lagonigro, M. S., Miselli, F., Greco, A., Gronchi, A., Casali, P. G., Ferrone, M. L., Fermeglia, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209639 · Cited by 104
Thijssen, M. A. M. A., Swinkels, D. W., Ruers, T. J. M., & de Kok, J. B. (2002) · PubMed · Cited by 103
Jiao, L., Zhu, J., Hassan, M. M., Evans, D. B., Abbruzzese, J. L., & Li, D. (2006) · Pancreas · doi:10.1097/01.mpa.0000246665.68869.d4 · Cited by 95
Autoimmunity versus tolerance: Can dying cells tip the balance?
Viorritto, I. C. B., Nikolov, N. P., & Siegel, R. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.07.012 · Cited by 89
Hsieh, J., Lin, S., Chang, M., Chen, F., Lu, C., Huang, T., Huang, Y., Huang, C., & Wang, J. (2005) · The American Surgeon · doi:10.1177/000313480507100413 · Cited by 87
Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients.
Combaret, V., Audoynaud, C., Iacono, I., Favrot, M., Schell, M., Bergeron, C., & Puisieux, A. (2002) · PubMed · Cited by 86
Detection of HER2 amplification in circulating free DNA in patients with breast cancer
Page, K., Hava, N., Ward, B., Brown, J., Guttery, D. S., Ruangpratheep, C., Blighe, K., Sharma, A., Walker, R. A., Coombes, R. C., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.89 · Cited by 86
Sorenson, G. D. (2000) · PubMed · Cited by 84
Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients
Daniotti, M., Vallacchi, V., Rivoltini, L., Patuzzo, R., Santinami, M., Arienti, F., Cutolo, G., Pierotti, M. A., Parmiani, G., & Rodolfo, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22598 · Cited by 83
Primary colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up
Cutsem, E. V., & Oliveira, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp126 · Cited by 79
Nakamura, T., Sueoka‐Aragane, N., Iwanaga, K., Sato, A., Komiya, K., Kobayashi, N., Hayashi, S., Hosomi, T., Hirai, M., Sueoka, E., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825f2821 · Cited by 75
Persistence of tumor DNA in plasma of breast cancer patients after mastectomy
Silva, J. M., Garcia, J. M., Domínguez, G., Silva, J., Miralles, C., Cantos, B., Coca, S., Provencio, M., España, P., & Bonilla, F. (2002) · Annals of Surgical Oncology · doi:10.1245/aso.2002.9.1.71 · Cited by 73
The Importance of Careful Blood Processing in Isolation of Cell‐Free DNA
PAGE, K., Powles, T., Slade, M. J., Bella, M. T. D., Walker, R. A., Coombes, R. C., & Shaw, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.042 · Cited by 71
The origin of extracellular DNA during the clearance of dead and dying cells
Pisetsky, D. S., & Fairhurst, A. (2007) · Autoimmunity · doi:10.1080/08916930701358826 · Cited by 71
Med1 plays a critical role in the development of tamoxifen resistance
Nagalingam, A., Tighiouart, M., Rydén, L., Joseph, L., Landberg, G., Saxena, N. K., & Sharma, D. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs105 · Cited by 70
Nucleic acids spontaneously released by living frog auricles
Stroun, M., & Anker, P. (1972) · Biochemical Journal · doi:10.1042/bj1280100pb · Cited by 69
Huang, X. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i4.692 · Cited by 67
Morgan, S. R., Whiteley, J. L., Donald, E. L., Smith, J. C., Eisenberg, M. T., Kallam, E., & Kam-Morgan, L. N. W. (2012) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s8798 · Cited by 67
Schwarzenbach, H., Eichelser, C., Kropidlowski, J., Janni, W., Rack, B. K., & Pantel, K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0142 · Cited by 67
Hompes, D., & Ruers, T. J. M. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.06.004 · Cited by 63
Hamana, K., Uzawa, K., Ogawara, K., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602635 · Cited by 61
Spindler, K. G., Mau‐Sørensen, M., Pallisgaard, N., Andersen, R. F., Havelund, B. M., Pløen, J., Lassen, U., & Jakobsen, A. K. M. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.776175 · Cited by 60
Rechsteiner, M., von Teichman, A., Nowicka, A., Sulser, T., Schraml, P., & Moch, H. (2011) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-48869 · Cited by 59
de Castro, D. G., Fearfield, L. A., Nathan, P., Tanière, P., Wallace, A. J., Brown, E. R., Harwood, C. A., Marsden, J. R., & Whittaker, S. J. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12248 · Cited by 58
Li, C., Hsu, H., Wu, T., Tsao, K., Sun, C., & Wu, J. T. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10081 · Cited by 51
Preferential Isolation of Fragmented DNA Enhances the Detection of Circulating Mutated k-ras DNA
Wang, M., Block, T. M., Steel, L., Brenner, D. E., & Su, Y. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026914 · Cited by 51
Camps, C., Lewintre, E. J., Cabrera‐Pastor, A., Blasco, A., Sanmartín, E., Gallach, S., Caballero, C., del Pozo, N., Rosell, R., Guijarro, R., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.09.005 · Cited by 50
Chen, Z., Feng, J., Buzin, C. H., Liu, Q., Weiss, L. M., Kernstine, K. H., Somlo, G., & Sommer, S. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007220 · Cited by 48
Müller, I., Beeger, C., Alix‐Panabières, C., Rébillard, X., Pantel, K., & Schwarzenbach, H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099333 · Cited by 45
Kuhlmann, J. D., Schwarzenbach, H., Wimberger, P., Poetsch, M., Kimmig, R., & Kasimir‐Bauer, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-325 · Cited by 44
Next-generation sequencing entering the clinical arena
Haas, J., Katus, H. A., & Meder, B. (2011) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2011.08.005 · Cited by 40
Influence of neuroblastoma stage on serum‐based detection of MYCN amplification
Combaret, V., Hogarty, M. D., London, W. B., McGrady, P., Iacono, I., Bréjon, S., Swerts, K., Noguera, R., Groß, N., Rousseau, R. F., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22009 · Cited by 40
Wu, C. C., Yu, C. R., Chang, G., Lai, J.-M., & Hsu, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.001 · Cited by 36
Shah, S., Ketterling, R. P., Goetz, M. P., Ingle, J. N., Reynolds, C. A., Perez, E. A., & Chen, B. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.07.001 · Cited by 36
Circulating Cell-Free Nucleic Acids: Promising Biomarkers of Hepatocellular Carcinoma
Zhou, J., Shi, Y., & Fan, J. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.013 · Cited by 35
Circulating MYCN DNA Predicts MYCN-Amplification in Neuroblastoma
Combaret, V., Bergeron, C., Noguera, R., Iacono, I., & Puisieux, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0170 · Cited by 33
Guadalajara, H., Domínguez–Berzosa, C., García‐Arranz, M., Herreros, M. D., Pascual, I., Baro, R. S., García-Olmo, D. C., & García‐Olmo, D. (2008) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2008.01.002 · Cited by 26
Liu, P., Liang, H., Xue, L., YANG, C., LIU, Y., ZHOU, K., & Jiang, X. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.566 · Cited by 20
K-ras Mutations in Circulating DNA From Pancreatic and Lung Cancers
Magistrelli, P., Neri, M., Granone, P., Cesario, A., Paleari, L., & Russo, P. (2008) · Pancreas · doi:10.1097/mpa.0b013e31815e72bc · Cited by 15
Weber, B., Sørensen, B. S., Knap, M. M., Madsen, H. H. T., Nexø, E., & Meldgaard, P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822e71f2 · Cited by 13
Cited by
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
Bera, K., Braman, N., Gupta, A., Velcheti, V., & Madabhushi, A. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00560-7 · Cited by 819
Metadata
- Authors
- Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2013-07-09
- Volume
- 10
- Issue
- 8
- Pages
- 472-484
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2089135124
- Cited by
- 1,819
- References
- 153
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.